This press release is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933, as amended, and does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.
Caelum Biosciences, Inc.
Michael Spector, President & Chief Executive Officer
Laura Bagby, Media Relations
To read more Press Release articles, click here.